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• Retrospective data from all patients who received 
alteplase for acute ischemic stroke from November 
2012- April 2019 compared to baseline (Jan 2012 –
October 2012)
• An estimated two million brain cells die every minute 
cerebral perfusion is impaired
• Best outcomes for acute ischemic stroke are achieved 
by decreasing the time from emergency department 
(ED) arrival to thrombolytic therapy
• Previously, alteplase was dosed and prepared in the 
pharmacy which contributed to prolonged door to 
needle (D2N)
Pharmacists Improve Door to Needle Times in the Emergency Department
Kevin Phan, Pharm D., BCCCP, APh, Megan Degener, Pharm D., BCCCP






• 407 patients received alteplase
• Average D2N decreased from 131 minutes at baseline to 45 minutes
• The largest decrease in average D2N was seen with the launch of the 
ED pharmacist role (   18 minutes), the expansion of the ED pharmacist 
coverage (   28 minutes), and pharmacist preparation of alteplase in CT 
(  17 minutes)
• Pharmacists directly impacted 
stroke care in the ED by 
decreasing D2N 
• Presence of a pharmacist in the 
ED enabled fast and safe 
delivery of alteplase
• Pharmacists also were able to 
perform rapid medication 
reconciliation and expedite 
antihypertensive therapies
• Having pharmacists as a part of 
the stroke team is a model that 
can be adopted by hospitals to 
enhance stroke care
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• To describe the impact of various pharmacist 
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Nov 2012 - Launch of ED 
Pharmacist Role
Sept 2014 - ED pharmacist 
Coverage Hours Expanded 
Nov 2015 – Pharmacist began to 
mix all tPA at bedside Jan 2016- Pharmacist began to track 
concurrent D2N timesApr 2017 – Pharmacist preparation of 
alteplase in CT Feb 2018 - Pharmacist developed 
annual tPA competency for all 
pharmacists
Jan 2019 - Pharmacist began to report 
D2N times at stroke meetings monthly
